Analysis of c-myc, PAI-1 and uPAR in patients with incisional hernias

Hernia

Volumn 12, Issue 3, 2008, Pages 285-288

  Rosch, R ^a   Binnebosel M ^a   Junge, K ^a   Lynen Jansen, P ^a   Mertens, P R ^a   Klinge, U ^a   Schumpelick, V ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

c myc; Incisional hernia; PAI; uPAR; Wound healing

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; MYC PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HERNIOPLASTY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCISIONAL HERNIA; MALE; PATHOGENESIS; POLARIZATION MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCAR FORMATION; SKIN SCAR; SURGICAL STAPLING; WOUND HEALING;

COLLAGEN; FEMALE; HERNIA, ABDOMINAL; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, CELL SURFACE; STATISTICS, NONPARAMETRIC; WOUND HEALING;

EID: 44649186858     PISSN: 12654906     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10029-007-0311-7     Document Type: Article

References (24)

1. McEntyre RL, Raffensperger JG (1977) Surgical complications of Ehlers-Danlos syndrome in children. J Pediatr Surg 12:531-535
2. Adye B, Luna G (1998) Incidence of abdominal wall hernia in aortic surgery. Am J Surg 175:400-402
3. Girotto JA, Malaisrie SC, Bulkely G, Manson PN (2000) Recurrent ventral herniation in Ehlers-Danlos syndrome. Plast Reconstr Surg 106:1520-1526
4. Augestad KM, Wilsgaard T, Solberg S (2002) Incisional hernia after surgery for abdominal aortic aneurysm. Tidsskr Nor Laegeforen 122:22-24
5. Papadimitriou D, Pitoulias G, Papaziogas B, Koutsias S, Vretzakis G, Argiriadou H, Papaziogas T (2002) Incidence of abdominal wall hernias in patients undergoing aortic surgery for aneurysm or occlusive disease. Vasa 31:111-114
6. Sorensen LT, Friis E, Jorgensen T, Vennits B, Andersen BR, Rasmussen GI, Kjaergaard J (2002) Smoking is a risk factor for recurrence of groin hernia. World J Surg 26:397-400
7. Sorensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jorgensen LN (2005) Smoking is a risk factor for incisional hernia. Arch Surg 140:119-123
8. Read RC (1970) Attenuation of the rectus sheath in inguinal herniation. Am J Surg 120:610-614
9. Bellon JM, Bujan J, Honduvilla NG, Jurado F, Gimeno MJ, Turnay J, Olmo N, Lizarbe MA (1997) Study of biochemical substrate and role of metalloproteinases in fascia transversalis from hernial processes. Eur J Clin Invest 27:510-516
10. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2000) Abnormal collagen I to III distribution in the skin of patients with incisional hernia. Eur Surg Res 32:43-48
11. Bellon JM, Bajo A, Ga-Honduvilla N, Gimeno MJ, Pascual G, Guerrero A, Bujan J (2001) Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression. Ann Surg 233:287-291
12. Klinge U, Si ZY, Zheng H, Schumpelick V, Bhardwaj RS, Klosterhalfen B (2001) Collagen I/III and matrix metalloproteinases (MMP) 1 and 13 in the fascia of patients with incisional hernias. J Invest Surg 14:47-54
13. Si Z, Rhanjit B, Rosch R, Rene PM, Klosterhalfen B, Klinge U (2002) Impaired balance of type I and type III procollagen mRNA in cultured fibroblasts of patients with incisional hernia. Surgery 131:324-331
14. Rosch R, Junge K, Knops M, Lynen P, Klinge U, Schumpelick V (2003) Analysis of collagen-interacting proteins in patients with incisional hernias. Langenbecks Arch Surg 387:427-432
15. Salameh JR, Talbott LM, May W, Gosheh B, Vig PJ, McDaniel DO (2007) Role of biomarkers in incisional hernias. Am Surg 73:561-567
16. Junge K, Klinge U, Rosch R, Mertens PR, Kirch J, Klosterhalfen B, Lynen P, Schumpelick V (2004) Decreased collagen type I/III ratio in patients with recurring hernia after implantation of alloplastic prostheses. Langenbecks Arch Surg 389:17-22
17. Remmele W SH (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138-140
18. Arumugam S, Jang YC, Chen-Jensen C, Gibran NS, Isik FF (1999) Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair. Surgery 125:587-593
19. Mignatti P, Rifkin DB (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117-137
20. Nicholl SM, Roztocil E, Davies MG (2006) Plasminogen activator system and vascular disease. Curr Vasc Pharmacol 4:101-116
21. Pelengaris S, Khan M (2003) The many faces of c-MYC. Arch Biochem Biophys 416:129-136
22. Hu Z, Lou L, Luo S (2002) Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars. Zhonghua Zheng Xing Wai Ke Za Zhi 18:165-167
23. Prendergast GC, Diamond LE, Dahl D, Cole MD (1990) The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol Cell Biol 10:1265-1269
24. Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M (2005) Molecular pathogenesis of chronic wounds: The role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167:59-69